Evidence map›Paper›PMID 19763515›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2009

Transgenic mouse technology: principles and methods.

T Rajendra Kumar, Melissa Larson, Huizhen Wang, Jeff McDermott, Illya Bronshteyn

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Zoological research · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Spontaneous and Induced Animal Models for Cancer Research.Diagnostics (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Insight intoInternational journal of molecular sciences · 2019
    Article
  11. Avian Bioreactor Systems: A Review.Molecular biotechnology · 2018
    Review
  12. Review
  13. Transgenic Mouse Models in Cancer Research.Frontiers in oncology · 2018
    Review
  14. Article
  15. Article
  16. Redirecting intracellular trafficking and the secretion pattern of FSH dramatically enhances ovarian function in mice.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

T Rajendra KumarDepartment of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
Melissa Larson
Huizhen Wang
Jeff McDermott
Illya Bronshteyn
University of Kansas Medical Center · USTarget (United States) · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ACKLEY, BRIAN DOUGLAS · 2001 to 2011
$38.1M
U KANSAS COBRE ADMINISTRATIVE COREP20RR024214 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KRIEG, ADAM J · 2007 to 2011
$10.8M
Genes regulated by activin receptor II signaling in gonadotropesR03HD056082 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KUMAR, T. RAJENDRA · 2008 to 2009
$147k
NCRR NIH HHS P20 RR016475NCRR NIH HHS P20 RR024214NCRR NIH HHS RR024214NICHD NIH HHS HD04394NICHD NIH HHS HD056082NICHD NIH HHS R03 HD056082NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

Introduction of foreign DNA into the mouse germ line is considered a major technical advancement in the fields of developmental biology and genetics. This technology now referred to as transgenic mouse technology has revolutionized virtually all fields of biology and provided new genetic approaches to model many human diseases in a whole animal context. Several hundreds of transgenic lines with expression of foreign genes specifically targeted to desired organelles/cells/tissues have been characterized. Further, the ability to spatio-temporally inactivate or activate gene expression in vivo using the "Cre-lox" technology has recently emerged as a powerful approach to understand various developmental processes including those relevant to molecular endocrinology. In this chapter, we will discuss the principles of transgenic mouse technology, and describe detailed methodology standardized at our institute.

Indexed as

Mice, TransgenicAnimalsFemaleGenes, ReporterMiceMicroinjectionsPolymerase Chain ReactionPseudopregnancyTransgenes

Identifiers

PMID19763515
PMCPMC4095860
OpenAlexW1732113068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.